Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk? ; volume:8 ; number:2 ; day:16 ; month:7 ; year:2019 ; pages:177-184 ; date:12.2019
Neurology and Therapy ; 8, Heft 2 (16.7.2019), 177-184, 12.2019
- Classification
-
Medizin, Gesundheit
- Creator
-
Rivera, Victor M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-019-0145-0
- URN
-
urn:nbn:de:101:1-2020070114053166440666
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rivera, Victor M.
- SpringerLink (Online service)
Other Objects (12)
Radiologic Gastrostomy: An Unmet Need!
Biomarkers of sarcopenia: an unmet need
Uterine Fibroids: Burden and Unmet Medical Need
Personalised medicine, unmet need or business strategy?
What do oncologists need to know about biosimilar products?
Towards a New Understanding of Unmet Medical Need
Why We Don’t Need “Unmet Needs”! On the Concepts of Unmet Need and Severity in Health-Care Priority Setting
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
An unmet clinical need: roads to remyelination in MS
Animal models for large vessel vasculitis – The unmet need
Cost–related unmet need for healthcare services in Kenya
Radiologic Gastrostomy: An Unmet Need!
Biomarkers of sarcopenia: an unmet need
Uterine Fibroids: Burden and Unmet Medical Need
Personalised medicine, unmet need or business strategy?
What do oncologists need to know about biosimilar products?
Towards a New Understanding of Unmet Medical Need
Why We Don’t Need “Unmet Needs”! On the Concepts of Unmet Need and Severity in Health-Care Priority Setting
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
An unmet clinical need: roads to remyelination in MS
Animal models for large vessel vasculitis – The unmet need
Cost–related unmet need for healthcare services in Kenya
Radiologic Gastrostomy: An Unmet Need!
Biomarkers of sarcopenia: an unmet need
Uterine Fibroids: Burden and Unmet Medical Need
Personalised medicine, unmet need or business strategy?
What do oncologists need to know about biosimilar products?
Towards a New Understanding of Unmet Medical Need
Why We Don’t Need “Unmet Needs”! On the Concepts of Unmet Need and Severity in Health-Care Priority Setting
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
An unmet clinical need: roads to remyelination in MS
Animal models for large vessel vasculitis – The unmet need